Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population

NCT02462499 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT02462499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02462499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
Lead sponsor
Semmelweis University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
September 30, 2016
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic central serous chorioretinopathy